UK Panel Urged To Keep Trial Transparency In The Spotlight
The recent momentum gained in the UK towards furthering clinical trial transparency needs to be kept up, say advocacy groups.
You may also be interested in...
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.
In the run-up to a hearing by a UK parliamentary committee on clinical trial transparency, a new report highlights continued non-compliance by some non-commercial sponsors. Concerns have also been raised about the effect of introducing sanctions.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”